Literature DB >> 11509411

Bacteriotherapy: the time has come.

P Huovinen.   

Abstract

Mesh:

Year:  2001        PMID: 11509411      PMCID: PMC1120965          DOI: 10.1136/bmj.323.7309.353

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  12 in total

1.  Control of antimicrobial resistance: time for action. The essentials of control are already well known.

Authors:  P Huovinen; O Cars
Journal:  BMJ       Date:  1998-09-05

2.  The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance.

Authors:  H Seppälä; T Klaukka; J Vuopio-Varkila; A Muotiala; H Helenius; K Lager; P Huovinen
Journal:  N Engl J Med       Date:  1997-08-14       Impact factor: 91.245

3.  Molecular analysis of commensal host-microbial relationships in the intestine.

Authors:  L V Hooper; M H Wong; A Thelin; L Hansson; P G Falk; J I Gordon
Journal:  Science       Date:  2001-02-02       Impact factor: 47.728

4.  New aspects of Salmonella infection in broiler production.

Authors:  E Nurmi; M Rantala
Journal:  Nature       Date:  1973-01-19       Impact factor: 49.962

5.  Antecedent antimicrobial use increases the risk of uncomplicated cystitis in young women.

Authors:  H S Smith; J P Hughes; T M Hooton; P Roberts; D Scholes; A Stergachis; A Stapleton; W E Stamm
Journal:  Clin Infect Dis       Date:  1997-07       Impact factor: 9.079

6.  Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial.

Authors:  K Hatakka; E Savilahti; A Pönkä; J H Meurman; T Poussa; L Näse; M Saxelin; R Korpela
Journal:  BMJ       Date:  2001-06-02

7.  Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients.

Authors:  M Tvede; J Rask-Madsen
Journal:  Lancet       Date:  1989-05-27       Impact factor: 79.321

8.  Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial.

Authors:  B J Rembacken; A M Snelling; P M Hawkey; D M Chalmers; A T Axon
Journal:  Lancet       Date:  1999-08-21       Impact factor: 79.321

9.  Recolonization with selected alpha-streptococci for prophylaxis of recurrent streptococcal pharyngotonsillitis--a randomized placebo-controlled multicentre study.

Authors:  K Roos; S E Holm; E Grahn-Håkansson; L Lagergren
Journal:  Scand J Infect Dis       Date:  1996

10.  A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease.

Authors:  L V McFarland; C M Surawicz; R N Greenberg; R Fekety; G W Elmer; K A Moyer; S A Melcher; K E Bowen; J L Cox; Z Noorani
Journal:  JAMA       Date:  1994 Jun 22-29       Impact factor: 56.272

View more
  13 in total

1.  Bacteriotherapy may be useful in treating bacterial vaginosis.

Authors:  D Taylor-Robinson; I Rosenstein
Journal:  BMJ       Date:  2001-11-10

2.  The Use of Probiotics in Head and Neck Infections.

Authors:  Kristian Roos; Stig Holm
Journal:  Curr Infect Dis Rep       Date:  2002-06       Impact factor: 3.725

3.  Prospecting of potentially probiotic lactic acid bacteria from bovine mammary ecosystem: imminent partners from bacteriotherapy against bovine mastitis.

Authors:  Raphael S Steinberg; Lilian C Silva E Silva; Marcelo R de Souza; Ronaldo B Reis; Adriano F Bicalho; João P S Nunes; Adriana A M Dias; Jacques R Nicoli; Elisabeth Neumann; Álvaro C Nunes
Journal:  Int Microbiol       Date:  2021-09-09       Impact factor: 2.479

Review 4.  Antibiotics in early life and obesity.

Authors:  Laura M Cox; Martin J Blaser
Journal:  Nat Rev Endocrinol       Date:  2014-12-09       Impact factor: 43.330

5.  Bacteriotherapy with Lactobacillus plantarum in burns.

Authors:  Maria C Peral; Miguel A Huaman Martinez; Juan C Valdez
Journal:  Int Wound J       Date:  2009-02       Impact factor: 3.315

6.  Oral administration of Lactobacillus strains isolated from breast milk as an alternative for the treatment of infectious mastitis during lactation.

Authors:  E Jiménez; L Fernández; A Maldonado; R Martín; M Olivares; J Xaus; J M Rodríguez
Journal:  Appl Environ Microbiol       Date:  2008-06-06       Impact factor: 4.792

7.  Lactobacillus paracasei SD1, a novel probiotic, reduces mutans streptococci in human volunteers: a randomized placebo-controlled trial.

Authors:  Rawee Teanpaisan; Supatcharin Piwat
Journal:  Clin Oral Investig       Date:  2013-07-28       Impact factor: 3.573

8.  Human microbiomics.

Authors:  J Rajendhran; P Gunasekaran
Journal:  Indian J Microbiol       Date:  2010-04-29       Impact factor: 2.461

Review 9.  Human intestinal microbiota and type 1 diabetes.

Authors:  Outi Vaarala
Journal:  Curr Diab Rep       Date:  2013-10       Impact factor: 4.810

Review 10.  The magic of magic bugs in oral cavity: Probiotics.

Authors:  Rangare Lakshman Anusha; Dilshad Umar; Bahija Basheer; Kusai Baroudi
Journal:  J Adv Pharm Technol Res       Date:  2015 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.